William Frazier Sells Shares of Viemed Healthcare
Viemed Healthcare's Chief Medical Officer, William Frazier, sold 10,000 shares on June 25.
Key Points
- William Frazier, Viemed Healthcare's Chief Medical Officer, sold 10,000 shares valued at $117,200 on June 25, 2026.
- Viemed Healthcare's stock traded near $11.63 with a market cap of approximately $445.9 million and a P/E ratio of 31.43.
- Forager Capital Management increased its stake in Viemed, while Vanguard Capital Management opened a new position.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
William Frazier, the Chief Medical Officer of Viemed Healthcare, Inc. (NasdaqCM: VMD), sold 10,000 shares of the company on June 25, 2026. The shares were sold at an average price of $11.72, bringing the total transaction value to $117,200. This was not a planned sale under a Rule 10b5-1 trading plan.
Other Institutional Activity in Viemed Healthcare
Several institutional investors have been active with Viemed Healthcare. Forager Capital Management, LLC increased its holdings by 40,000 shares, ending with 2,825,871 shares valued at about $26.03 million, a 1.4% increase. Vanguard Capital Management LLC opened a new position, acquiring 1,303,384 shares worth approximately $12.00 million. Meanwhile, Ameriprise Financial Inc. added 75,506 shares, increasing its stake by 9.2% to 898,319 shares valued at $8.27 million. On the other hand, BlackRock, Inc. reduced its position slightly by 3,514 shares, maintaining 4,622,562 shares valued at around $42.57 million.
Viemed Healthcare, Inc. Stock Up 31.9%
Shares of Viemed Healthcare were trading near $11.63 on Sunday. The company has a market capitalization of roughly $445.9 million and a P/E ratio of 31.43. Viemed's stock has seen a 52-week range between $5.93 and $11.88. The 50-day moving average is $9.89, while the 200-day moving average stands at $8.19. Viemed has a current ratio of 1.22 and a quick ratio of 1.01, with a debt-to-equity ratio of 8.53.
$VMD stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
Viemed Healthcare reported revenue of approximately $286.6 million, reflecting a growth rate of 27.5%. The company's earnings per share (EPS) stood at $0.37, with a net margin of 5.2% and a return on equity of 10.9%. The next earnings report is expected on August 5, 2026.
Insider Buying and Selling at Viemed Healthcare, Inc.
On June 25, 2026, William Frazier sold 10,000 shares at an average price of $11.72. Earlier the same day, he purchased 10,000 shares at $1.81. Timothy Smokoff sold 20,000 shares on June 24, 2026, at an average price of $11.50. Michael Moore, the President, sold 65,000 shares on March 20, 2026, at a price of $8.77, and another 40,232 shares on March 19, 2026, at $9.21.
Analysts Set New Price Targets
Lake Street reiterated its 'buy' rating for Viemed Healthcare on May 7, 2024, with a price target of $15. The consensus among analysts is a 'buy' recommendation, with an average target price of $11 based on one analyst opinion.
About Viemed Healthcare
Viemed Healthcare, Inc., headquartered in Lafayette, Louisiana, provides home medical equipment and post-acute respiratory healthcare services in the United States. The company focuses on respiratory disease management, offering solutions for conditions like chronic obstructive pulmonary disease (COPD). It provides non-invasive ventilation, percussion vests, and other therapies, as well as invasive and non-invasive ventilation equipment. Founded in 2006, Viemed also offers sleep apnea management and in-home testing services, along with healthcare staffing and recruitment services.
Bottom Line
William Frazier's recent sale of Viemed Healthcare shares highlights insider activity within the company. Investors often track such transactions as part of their analysis, although it's important to note that these filings reflect past actions and may not indicate future intentions. Viemed Healthcare continues to show growth, with recent earnings and institutional interest suggesting ongoing confidence in its business model.
Get Viemed Healthcare, Inc. alerts
New 13F filings, insider trades, and analyst moves on $VMD, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.